Ambeed.cn

首页 / / / / Isofraxidin/异嗪皮啶

Isofraxidin/异嗪皮啶 {[allProObj[0].p_purity_real_show]}

货号:A480950 同义名: 异秦皮啶

Isofraxidin是一种从 Sarcandra glabra (Thunb.) Nakai 草药中分离纯化的天然产物,具有显著的镇痛和抗炎活性,可能通过调节促炎细胞因子 TNF-α 和 p38 及 ERK1/2 的磷酸化来介导其作用。

Isofraxidin/异嗪皮啶 化学结构 CAS号:486-21-5
Isofraxidin/异嗪皮啶 化学结构
CAS号:486-21-5
Isofraxidin/异嗪皮啶 3D分子结构
CAS号:486-21-5
Isofraxidin/异嗪皮啶 化学结构 CAS号:486-21-5
Isofraxidin/异嗪皮啶 3D分子结构 CAS号:486-21-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Isofraxidin/异嗪皮啶 纯度/质量文件 产品仅供科研

货号:A480950 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Isofraxidin/异嗪皮啶 生物活性

描述 Isofraxidin, a natural product isolated and purified from the herbs of Sarcandra glabra (Thunb.) Nakai, possesses significant analgesic and anti-inflammatory activities that may be mediated through the regulation of pro-inflammatory cytokines, TNF-α and the phosphorylation of p38 and ERK1/2.

Isofraxidin/异嗪皮啶 细胞实验

Cell Line
Concentration Treated Time Description References
RAW 264.7 macrophages 0.03, 0.06, and 0.06 mmol 24 hours To investigate the effect of C + R + I on LPS-induced inflammatory factors and oxidative stress in RAW 264.7 macrophages. Results showed that C + R + I significantly suppressed the levels of nitric oxide (NO), pro-inflammatory cytokines, and inhibited iNOS and COX-2 expression. Front Pharmacol. 2021 Jan 11;11:580064
Bone marrow-derived macrophages (BMMs) 12.5 µM 8 hours To evaluate the effect of isofraxidin on RANKL-induced NFATc1 transcriptional activity, results showed that isofraxidin inhibited NFATc1 activation. Cell Transplant. 2021 Jan-Dec;30:963689721990321
Bone marrow-derived macrophages (BMMs) 6.25 and 12.5 µM 4 days To evaluate the effect of isofraxidin on RANKL-induced osteoclast formation in BMMs, results showed that isofraxidin inhibited TRAP activity and osteoclast formation. Cell Transplant. 2021 Jan-Dec;30:963689721990321
Bone marrow-derived macrophages (BMMs) 6.25 and 12.5 µM 24 hours To evaluate the effect of isofraxidin on BMMs cell viability, results showed that 6.25 and 12.5 µM concentrations did not affect cell viability. Cell Transplant. 2021 Jan-Dec;30:963689721990321

Isofraxidin/异嗪皮啶 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice Chronic unpredictable mild stress (CUMS)-induced depressive model Oral gavage 3, 10, 30 mg/kg Once daily for 4 weeks Isofraxidin significantly reversed CUMS-induced decrease in body weight gain, sucrose preference, locomotor activity, and increased immobility time in the forced swimming test (FST) and tail suspension test (TST). Additionally, isofraxidin decreased serum levels of corticosterone (CORT), adrenocorticotropic hormone (ACTH), and hypothalamic corticotropin-releasing hormone (CRH), suppressed the expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 in the hippocampus, and inhibited CUMS-induced activation of nuclear factor kappa B (NF-κB) and NOD-like receptor protein 3 (NLRP3) inflammasomes in the hippocampus. Brain Sci. 2022 Oct 11;12(10):1376
BALB/c mice LPS-induced acute lung injury model Intraperitoneal injection High dose (50, 20, and 20 mg/kg), middle dose (25, 10, and 10 mg/kg), low dose (12.5, 5, and 5 mg/kg) Once daily for three days To investigate the protective effect of C + R + I on LPS-induced acute lung injury in mice. Results showed that C + R + I significantly alleviated lung histopathological damage, reduced inflammatory cell infiltration, and inhibited the activation of the MAPK-NF-κB signaling pathway. Front Pharmacol. 2021 Jan 11;11:580064
Swiss albino mice LPS-induced cytokine release syndrome Intraperitoneal 15 mg/kg Once daily for 3 days Isofraxidin alone or in combination with methylprednisolone ameliorates LPS-induced inflammatory and oxidative stress damage in mice, reduces inflammatory and oxidative stress markers, and prevents LPS-induced liver and lung tissue damage. Biomedicines. 2025 Mar 7;13(3):653

Isofraxidin/异嗪皮啶 参考文献

[1]Liu L, Mu Q, et al. Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes. Immunobiology. 2015 Mar;220(3):406-13.

[2]Niu X, Wang Y, et al. Protective effects of Isofraxidin against lipopolysaccharide-induced acute lung injury in mice. Int Immunopharmacol. 2015 Feb;24(2):432-9.

Isofraxidin/异嗪皮啶 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.50mL

0.90mL

0.45mL

22.50mL

4.50mL

2.25mL

45.01mL

9.00mL

4.50mL

Isofraxidin/异嗪皮啶 技术信息

CAS号486-21-5
分子式C11H10O5
分子量 222.19
SMILES Code O=C1C=CC2=CC(OC)=C(O)C(OC)=C2O1
MDL No. MFCD00221757
别名 异秦皮啶
运输蓝冰
InChI Key HOEVRHHMDJKUMZ-UHFFFAOYSA-N
Pubchem ID 5318565
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 250 mg/mL(1125.14 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。